Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial
Abstract Objectives To evaluate the efficacy of early treatment with prednisone to decrease the progression of COVID-19 pneumonia. Trial design This is a pragmatic, non-blinded, randomized, two arms, parallel trial. Participants Patients between 18 and 90 years, with COVID-19 pneumonia, confirmed by...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05046-6 |